Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $19.37 and last traded at $19.37, with a volume of 69151 shares trading hands. The stock had previously closed at $18.51.
Ascentage Pharma Group International Price Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- How to Profit From Growth Investing
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Using the MarketBeat Dividend Tax Calculator
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
